- Home
- CTKB vs CCCX Comparison
CTKB vs CCCX Comparison
Compare CTKB & CCCX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTKB
- CCCX
- Stock Information
- Founded
- CTKB 1990
- CCCX 2024
- Country
- CTKB United States
- CCCX United States
- Employees
- CTKB N/A
- CCCX N/A
- Industry
- CTKB Biotechnology: Electromedical & Electrotherapeutic Apparatus
- CCCX Blank Checks
- Sector
- CTKB Health Care
- CCCX Finance
- Exchange
- CTKB Nasdaq
- CCCX Nasdaq
- Market Cap
- CTKB 526.7M
- CCCX 527.0M
- IPO Year
- CTKB 2021
- CCCX 2025
- Fundamental
- Price
- CTKB $4.02
- CCCX $10.11
- Analyst Decision
- CTKB Hold
- CCCX
- Analyst Count
- CTKB 4
- CCCX 0
- Target Price
- CTKB $6.00
- CCCX N/A
- AVG Volume (30 Days)
- CTKB 1.0M
- CCCX 11.6K
- Earning Date
- CTKB 11-04-2025
- CCCX 01-01-0001
- Dividend Yield
- CTKB N/A
- CCCX N/A
- EPS Growth
- CTKB N/A
- CCCX N/A
- EPS
- CTKB N/A
- CCCX 0.14
- Revenue
- CTKB $196,035,000.00
- CCCX N/A
- Revenue This Year
- CTKB $0.09
- CCCX N/A
- Revenue Next Year
- CTKB $7.45
- CCCX N/A
- P/E Ratio
- CTKB N/A
- CCCX $269.43
- Revenue Growth
- CTKB N/A
- CCCX N/A
- 52 Week Low
- CTKB $2.37
- CCCX $10.22
- 52 Week High
- CTKB $7.63
- CCCX $10.50
- Technical
- Relative Strength Index (RSI)
- CTKB 53.78
- CCCX N/A
- Support Level
- CTKB $3.85
- CCCX N/A
- Resistance Level
- CTKB $4.23
- CCCX N/A
- Average True Range (ATR)
- CTKB 0.17
- CCCX 0.00
- MACD
- CTKB -0.04
- CCCX 0.00
- Stochastic Oscillator
- CTKB 40.70
- CCCX 0.00
About CTKB Cytek Biosciences Inc.
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Cytek Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance. Geographically, the company generates a majority of its revenue from the United States.
About CCCX Churchill Capital Corp X Class A Ordinary Shares
Churchill Capital Corp X is a blank check company.